🏅 FDA Orphan Designation
Galzin
Zinc acetate
Manufacturer: Eton Pharmaceuticals, Inc
Indicated for:
Wilson diseaseOrphan
FDA-Approved Indications (1)
Wilson diseaseOrphan Designation
For maintenance treatment of patients with Wilson's disease who have been initially treated with a chelating agent.
Indications & Usage
INDICATIONS AND USAGE Zinc acetate therapy is indicated for maintenance treatment of patients with Wilson’s disease who have been initially treated with a chelating agent (See PRECAUTIONS: Monitoring Patients ).
💙 Support Programs
View all →Galzin
Eton Pharmaceuticals
Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.
Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.